Hinge Health reported cash from operations of $101.41M and free cash flow of $99.68M for the quarter ended Jun 2026, up 401.4% year over year. This cash flow statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | -12.96M | 0.34M | 27.12M | 17.14M | -575.65M | -1.84M | 32.12M | 35.13M | 43.69M |
| Share-based CompensationStock Comp. | 0.31M | 0.12M | 0.01M | 12.10M | 12.19M | 34.85M | 17.17M | 11.69M | 19.09M |
| Deferred Taxes | 0.01M | 0.09M | 0.05M | -0.09M | 0.01M | ||||
| Asset Writedowns and ImpairmentWritedown | 1.31M | ||||||||
| Cash from OperationsCash from Ops. | 28.40M | 38.34M | 4.92M | 20.23M | 82.40M | 63.89M | 43.08M | 101.41M | |
| Depreciation, Depletion & Amortization | |||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | -0.08M | -0.24M | -0.05M | -0.28M | -0.05M | 0.01M | -0.14M | -0.57M | |
| Depreciation & Amortization (CF)Dep. & Amort. | 1.42M | 1.37M | 1.30M | 1.34M | 1.26M | 1.22M | 1.17M | 1.06M | |
| Change in Working Capital | |||||||||
| Change in ReceivablesChange Receivables | -6.05M | -15.89M | 34.28M | 25.30M | -11.97M | -20.98M | 48.86M | 12.12M | |
| Change in InventoryChange Inventory | -2.69M | 3.22M | 1.91M | 1.20M | -0.17M | 1.82M | -1.47M | 2.60M | |
| Change in Accured ExpensesChange Accured Exp. | -9.53M | -10.81M | 15.71M | -43.36M | -10.67M | -25.26M | -20.60M | -28.48M | |
| Other Working Capital ChangesOther WC Changes | 22.67M | 7.56M | -0.30M | 57.81M | 24.56M | 1.16M | 39.91M | 75.70M | |
| Investing Activities | |||||||||
| Capital ExpendituresCapex | 0.55M | 0.87M | 0.71M | 1.63M | 1.06M | 1.96M | 1.45M | 1.73M | |
| Acquisitions | 4.00M | ||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 83.88M | 81.19M | 73.60M | 90.96M | 85.26M | 118.78M | 108.57M | 61.39M | |
| Cash from Investing ActivitiesCash from Investing | 2.53M | -3.11M | -21.33M | 4.02M | -58.76M | -37.70M | 48.08M | 28.62M | |
| Financing Activities | |||||||||
| Other financing activitiesOther financing | 0.12M | 0.21M | 0.10M | 255.58M | 0.41M | 0.27M | |||
| Cash from Financing ActivitiesCash from Financing | -0.02M | -2.33M | 4.10M | -75.56M | 0.53M | -79.55M | -112.85M | -30.48M | |
| Additional items | |||||||||
| Change in Cash | 30.91M | 32.89M | -12.30M | -51.31M | 24.17M | -53.35M | -21.68M | 99.55M | |
| Free Cash FlowFCF | 27.85M | 37.47M | 4.22M | 18.59M | 81.33M | 61.94M | 41.64M | 99.68M | |
| Net Cash FlowNCF | 30.91M | 32.89M | -12.30M | -51.31M | 24.17M | -53.35M | -21.68M | 99.55M |